Neuroprotection therapies for Huntington's disease

被引：0

作者：

Brouillet, E ^{[1
]}

Jacquard, C ^{[1
]}

Hantraye, P ^{[1
]}

机构：

[1] CNRS, CEA, Dept Med Res, URA 2210,SHFJ, F-91405 Orsay, France

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S167 / S167

页数：1

共 50 条

[1] Neuroprotection in Huntington's disease
Bonelli, RM
Hödl, AK
Kapfhammer, HP
LETTERS IN DRUG DESIGN & DISCOVERY, 2005, 2 (02) : 143 - 147
[2] Neuroprotection in Huntington's disease: Minocycline
Bonelli, RM
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S367 - S368
[3] Paradigm for Neuroprotection in Presymptomatic Huntington's Disease
Rosas, H. Diana
Doros, Gheorghe
Gevorkian, Sona
Salat, David H.
Reuter, Martin
Fischl, Bruce
Malarick, Keith
Matson, Wayne R.
Scherzer, Clemens R.
Ferrante, Robert J.
Hersch, Steven M.
ANNALS OF NEUROLOGY, 2012, 72 : S104 - S104
[4] Antidepressants for neuroprotection in Huntington's disease: A review
Jamwal, Sumit
Kumar, Puneet
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 : 33 - 42
[5] Antiglutamate therapies in Huntington's disease
Kieburtz, K
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (55): : 97 - 102
[6] Emerging therapies in Huntington?s disease
Bashir, Hassaan
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (10) : 983 - 995
[7] Experimental Therapies for Huntington's Disease
Rosser, A.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 32 - 32
[8] Revisiting safety of minocycline as neuroprotection in Huntington's disease
Reynolds, Norman
MOVEMENT DISORDERS, 2007, 22 (02) : 292 - 292
[9] Neuroprotection and brain cholesterol biosynthesis in Huntington's disease
Valenza, Marta
Cattaneo, Elena
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (37) : 15999 - 15999
[10] Neuroprotection for Huntington's disease: Ready, set, slow
Hersch, Steven M.
Rosas, H. Diana
NEUROTHERAPEUTICS, 2008, 5 (02) : 226 - 236

← 1 2 3 4 5 →